1. Home
  2. LION vs AGIO Comparison

LION vs AGIO Comparison

Compare LION & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LION
  • AGIO
  • Stock Information
  • Founded
  • LION 1997
  • AGIO 2007
  • Country
  • LION United States
  • AGIO United States
  • Employees
  • LION N/A
  • AGIO N/A
  • Industry
  • LION Movies/Entertainment
  • AGIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • LION Consumer Discretionary
  • AGIO Health Care
  • Exchange
  • LION Nasdaq
  • AGIO Nasdaq
  • Market Cap
  • LION 1.6B
  • AGIO 1.4B
  • IPO Year
  • LION N/A
  • AGIO 2013
  • Fundamental
  • Price
  • LION $6.55
  • AGIO $40.00
  • Analyst Decision
  • LION Strong Buy
  • AGIO Buy
  • Analyst Count
  • LION 6
  • AGIO 6
  • Target Price
  • LION $9.58
  • AGIO $54.60
  • AVG Volume (30 Days)
  • LION 2.3M
  • AGIO 659.0K
  • Earning Date
  • LION 08-07-2025
  • AGIO 07-31-2025
  • Dividend Yield
  • LION N/A
  • AGIO N/A
  • EPS Growth
  • LION N/A
  • AGIO N/A
  • EPS
  • LION N/A
  • AGIO 11.45
  • Revenue
  • LION $3,947,900,000.00
  • AGIO $37,035,000.00
  • Revenue This Year
  • LION N/A
  • AGIO $22.30
  • Revenue Next Year
  • LION $7.22
  • AGIO $219.19
  • P/E Ratio
  • LION N/A
  • AGIO $3.49
  • Revenue Growth
  • LION N/A
  • AGIO 25.96
  • 52 Week Low
  • LION $5.55
  • AGIO $23.42
  • 52 Week High
  • LION $8.50
  • AGIO $62.58
  • Technical
  • Relative Strength Index (RSI)
  • LION 55.26
  • AGIO 65.57
  • Support Level
  • LION $6.33
  • AGIO $38.48
  • Resistance Level
  • LION $6.80
  • AGIO $41.74
  • Average True Range (ATR)
  • LION 0.32
  • AGIO 1.51
  • MACD
  • LION 0.05
  • AGIO -0.03
  • Stochastic Oscillator
  • LION 68.73
  • AGIO 73.87

About LION Lionsgate Studios Corp. Common Shares

Lionsgate Studios Corp is a company encompasses world-class motion picture and television studio operations and the STARZ-branded premium global subscription platforms to bring a unique and varied portfolio of entertainment to consumers around the world. The Studio Business consists of the Motion Picture and Television Production reportable segments, together with substantially all of Lionsgate's corporate general and administrative costs. Motion Picture consists of the development and production of feature films, acquisition of North American and worldwide distribution rights. Television Production consists of the development, production and worldwide distribution of television productions including television series, television movies and mini-series, and non-fiction programming.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company focused on the field of cellular metabolism to create differentiated medicines for rare diseases, with a focus on classical hematology. The company's primary focus is to develop potentially transformative small-molecule medicines. Its product candidate, Pyrukynd (mitapivat), is an activator of both wild-type and mutant pyruvate kinase enzymes, developed for the treatment of hemolytic anemias. The other drug candidates in its pipeline include Tebapivat (PK activator), being developed as a potential treatment for MDS-associated anemia and sickle cell disease, AG-181 (PAH stabilizer), AG-236, and others.

Share on Social Networks: